Clinical trials · New York, NY
Type 2 diabetes clinical trials in New York
We’re tracking 56 recruiting type 2 diabetes studies with a site in or near New York — including Early Phase 1, Phase 1, Phase 1/Phase 2, Phase 2, Phase 3 and Phase 4 studies, each written for real people, not researchers.
Recruiting studies near New York
- NCT06919354RecruitingPhase 1
Study of GNTI-122 for new type 1 diabetes
This study tests a new treatment called GNTI-122 for adults recently diagnosed with type 1 diabetes who still make some insulin. It aims to see if the treatment can help protect the cells that produce insulin.
New York, New YorkAges 18–55 - NCT07064473RecruitingPhase 3
Testing vicadrostat plus empagliflozin for diabetes, high blood pressure, and heart disease
This study tests a new pill called vicadrostat taken with another medicine (empagliflozin) to see if it helps people with type 2 diabetes, high blood pressure, and heart disease. It may reduce the risk of heart problems, but you must not have had heart failure or use certain other heart medications.
New York, New YorkAges 18 years+ - NCT06329544Recruiting
Study of a high-fructose diet and gut health
This trial tests how a high-fructose diet affects your gut bacteria and overall metabolic health. It is for people who already know they don't absorb fructose well (fructose malabsorbers) and want to understand how this sugar impacts their body.
New York, New YorkAges 25–45 - NCT06860516Recruiting
HLA Demographics Study in Adults With Type 1 Diabetes
This study (NCT06860516) is an observational trial of adults aged 18-55 with type 1 diabetes diagnosed within 6 months. It aims to collect demographic and HLA data.
New York, New YorkAges 18–55 - NCT07216508Recruiting
Liver Transplant Blood Sugar Monitoring Study
This study tests whether a continuous glucose monitor (CGM) can help manage blood sugar levels in patients who have just received a liver transplant and have high blood sugar in the hospital.
New York, New YorkAges 18 years+ - NCT05641753RecruitingPhase 4
LDL-lowering study for adults with type 1 diabetes
This study looks at cholesterol lowering in adults with type 1 diabetes and whether it reduces “residual risk,” meaning risk that may remain even with current care. You may be asked to take cholesterol-focused treatment and complete blood tests to track LDL (“bad cholesterol”).
New York, New YorkAges 18–89 - NCT04334707Recruiting
Study kidney damage in people with long-term diabetes
This study is looking at different kidney health patterns in people with diabetes, especially diabetic kidney disease and people who have not developed kidney damage despite long-term diabetes. It may help researchers understand why kidney problems happen—and what protective factors might prevent them.
New York, New YorkAges 18 years+ - NCT06112418Recruiting
Personalized vs standard care to prevent heart attacks
This trial compares two ways to prevent heart attacks and strokes: one uses a special heart CT scan to guide care, the other uses standard risk factors like blood pressure and cholesterol. You may be eligible if you are older (men over 55, women over 65) and have diabetes, prediabetes, or metabolic syndrome.
New York, New YorkAges 55 years+ - NCT03389100Enrolling by invitationPhase 2
Tau PET brain scan study for people without dementia
This trial studies how tau (a protein linked to Alzheimer’s and related conditions) shows up on a special brain scan called tau PET. It also uses MRI and blood work to understand brain changes and who may be at risk, helping researchers improve future diagnosis.
New York, New YorkAges 55–69 - NCT06319716Recruiting
Videos and coaching to help Chinese Americans with diabetes
This study tests whether short videos and support from a community health worker can help Chinese Americans manage their type 2 diabetes. If you join, you'll receive helpful videos and guidance to improve your blood sugar control.
New York, New YorkAges 18 years+ - NCT05762107RecruitingPhase 2
Drug ZT-01 to reduce low blood sugar at night
This Phase 2 study tests ZT-01 to help prevent night-time low blood sugar (hypoglycemia) in people with type 1 diabetes. It may help if you’ve had low blood sugar during sleep or are at high risk based on recent glucose monitoring.
New York, New YorkAges 18–75 - NCT07142252RecruitingPhase 2
New drug for recently diagnosed type 1 diabetes
This trial tests a new medicine (rezpegaldesleukin) to see if it can help preserve the body's ability to make some insulin in people recently diagnosed with type 1 diabetes. It's for children and adults diagnosed within the past 100 days.
New York, New YorkAges 8–45 - NCT07521475Recruiting
Fully Closed Loop Insulin Pump for Type 2 Diabetes
This study tests a new automated insulin pump system (Omnipod) that adjusts insulin doses on its own throughout the day for people with type 2 diabetes. The goal is to see if it helps keep blood sugar levels more stable while reducing the burden of manual insulin management.
New York, New YorkAges 18–75 - NCT00097292Recruiting
Preventing Type 1 Diabetes in At-Risk People
This study looks for people at high risk of developing type 1 diabetes (based on family history or blood markers) and follows them over time to understand disease development. The goal is to eventually prevent or delay type 1 diabetes in people who don't have it yet.
New York, New YorkAges 2–45 - NCT06783309RecruitingPhase 1/Phase 2
Testing CNP-103 for newly diagnosed type 1 diabetes
This trial tests a new study drug called CNP-103 for people ages 12-35 who were recently diagnosed (within 6 months) with stage 3 type 1 diabetes. The goal is to see if the drug can help preserve the body's ability to make some insulin, potentially slowing the need for more insulin shots.
New York, New YorkAges 12–35 - NCT05390892RecruitingPhase 4
Preventing kidney and heart damage in type 2 diabetes
This study tests whether diabetes medicines can help prevent worsening heart and kidney problems in people with type 2 diabetes. You’ll be assigned by chance to one of these medicine types, and your other care will be adjusted for safety.
New York, New YorkAges 40–80 - NCT07773779Recruiting
App and nutrition support for blood sugar control
This study tests a smartphone app combined with dietary guidance to help adults with type 1 or type 2 diabetes improve their blood sugar levels. Participants will use the app with their continuous glucose monitor to track meals and get personalized support, with the goal of better glycemic control and quality of life.
New York, New YorkAges 18–75 - NCT05884775Recruiting
Diabetes texting tool to track symptoms and improve care
This study tests a new phone/text-based system that asks people with type 2 diabetes about how they’re doing between visits. The goal is to help diabetes care and support better blood sugar control.
New York, New YorkAges 18 years+ - NCT06203106Recruiting
NYSCF Scientific Discovery Biobank
This study collects blood, saliva, or skin samples from people with certain neurological conditions and from healthy volunteers to help researchers better understand and find treatments for these diseases.
New York, New YorkAges 4 weeks+ - NCT06525259Recruiting
Study on risk factors for type 2 diabetes in youth
This study looks for children and teens who are at high risk of developing type 2 diabetes to understand what factors lead to it. If your child is overweight, has slightly high blood sugar, and is in early to mid-puberty, they may be able to join.
New York, New YorkAges 8–15 - NCT06319703Recruiting
Diabetes help for Chinese immigrants with high blood sugar
This study tests a video-based program to help Chinese immigrants manage type 2 diabetes. If you have high HbA1c, a smartphone, and are willing to watch short videos, this trial may help you improve your blood sugar control.
New York, New YorkAges 18–70 - NCT07209527Enrolling by invitationEarly Phase 1
Truway diagnostic tools in primary care
This trial tests new diagnostic tools that doctors can use in primary care. Researchers want to see if these tools help find the right diagnosis faster and more accurately.
New York, New YorkAges Any age - NCT07088068RecruitingPhase 3
Teplizumab for newly diagnosed type 1 diabetes
This study tests whether teplizumab can help keep the body making insulin in people recently diagnosed with type 1 diabetes. It is for children and young adults aged 1 to 25, and compares the drug against a placebo.
New York, New YorkAges 1–25 - NCT06897475RecruitingPhase 2
Study of LY3457263 for type 2 diabetes on semaglutide or tirzepatide
This study tests if adding LY3457263 helps lower blood sugar in people with type 2 diabetes who are already taking a stable dose of semaglutide or tirzepatide. You will be randomly assigned to get either LY3457263 or a placebo.
Long Island City, New YorkAges 18–75
Hear when a new Type 2 diabetes trial opens near New York, NY
We’ll email you when one opens near New York, NY — at most once a week, no account needed, unsubscribe anytime.
Type 2 diabetes trials in other cities
Where these studies are running near New York
Institutions with a site for the recruiting type 2 diabetes studies listed above.
- NYU Langone Health · 6 studies
- Columbia University Irving Medical Center · 5 studies
- Mount Sinai Health System · 4 studies
- Icahn School of Medicine at Mount Sinai · 2 studies
- Mount Sinai Hospital · 2 studies
- NYC Research INC · 2 studies
- Advanced Heart and Vascular Institute of Hunterdon
- Advanced Heart Care, LLC
What taking part in a type 2 diabetes study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting type 2 diabetes studies in New York.
Common questions
- Are there type 2 diabetes clinical trials near New York?
- Yes. We're currently tracking 56 recruiting type 2 diabetes studies with a site near New York, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a type 2 diabetes study near New York?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in New York to take part?
- Not necessarily. These studies have a site near New York, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a type 2 diabetes trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New type 2 diabetes studies open near New York regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.